[1] |
World Health Organization. Tobacco-Key facts[EB/OL]. (2023-07-31)[2024-05-11]. https://www.who.int/news-room/fact-sheets/detail/tobacco. |
[2] |
World Health Organization. Toolkit for delivering the 5A’s and 5R’s brief tobacco interventions in primary care[EB/OL]. (2014-05-23)[2024-05-11]. https://www.who.int/publications/i/item/9789241506946. |
[3] |
World Health Organization. WHO report on the global tobacco epidemic: offer help to quit tobacco use, 2019: offer help to quit tobacco use[EB/OL]. (2019)[2024-05-11]. https://iris.who.int/handle/10665/326043. |
[4] |
VALLIANT S N, BURBAGE S C, PATHAK S, et al. Pharmacists as accessible health care providers: quantifying the opportunity[J]. J Manag Care Spec Pharm, 2022, 28(1):85-90. |
[5] |
U. S. Food and Drug Administration. Want to Quit Smoking? FDA-Approved and FDA-Cleared Cessation Products Can Help[EB/OL]. (2022-07-21)[2024-05-11]. https://www.fda.gov/consumers/consumer-updates/want-quit-smoking-fda-approved-and-fda-cleared-cessation-products-can-help. |
[6] |
EL HAJJ M S, SHEIKH ALI S A S, AWAISU A, et al. A pharmacist-delivered smoking cessation program in Qatar: an exploration of pharmacists' and patients' perspectives of the program[J]. Int J Clin Pharm, 2021, 43(6):1574-1583. doi: 10.1007/s11096-021-01286-3 |
[7] |
SUI C F, MING L C. Chapter 53 - Pharmacist-led Smoking Cessation Services: Current and Future Perspectives[EB/OL]. (2019)[2024-05-11]. https://www.sciencedirect.com/science/article/pii/B9780128130353000538. |
[8] |
DAVE E. Smoking cessation services: how nicotine replacement therapy and counselling through pharmacy can support adherence and quitting[EB/OL]. (2018-01-02)[2024-05-11]. https://pharmaceutical-journal.com/article/ld/smoking-cessation-services-how-nicotine-replacement-therapy-and-counselling-through-pharmacy-can-support-adherence-and-quitting#fn_4. |
[9] |
CONDINHO M, RAMALHINHO I, SINOGAS C. Smoking cessation at the community pharmacy: determinants of success from a real-life practice[J]. Pharmacy, 2021, 9(3):143. doi: 10.3390/pharmacy9030143 |
[10] |
CHENG H M, LIU W C, CHUA G, et al. Impact of a pharmacy-led smoking cessation clinic in a dermatology centre[J]. Singapore Med J, 2019, 60(1):31-33. doi: 10.11622/smedj.2018063 |
[11] |
World Health Organization Regional Office for Europe. Pharmacists and action on tobacco Copenhagen, Denmark: EuroPharm Forum Smoking Cessation Task Force[EB/OL]. (1998)[2024-05-11]. http://apps.who.int/iris/bitstream/10665/108128/1/E61288.pdf. |
[12] |
World Health Organization. WHO Framework Convention on Tobacco Control[EB/OL]. (2003)[2024-05-11]. https://apps.who.int/iris/bitstream/handle/10665/42811/9241591013.pdf. |
[13] |
World Health Organization. The WHO Framework Convention on Tobacco Control: an overview[EB/OL]. (2021-03-05)[2024-05-11]. https://fctc.who.int/publications/m/item/the-who-framework-convention-on-tobacco-control-an-overview. |
[14] |
World Health Organization. WHO Framework Convention on Tobacco Control - Parties[EB/OL]. (2021-03-03)[2024-05-11]. https://fctc.who.int/who-fctc/overview/parties. |
[15] |
World Health Organization. It’s time to invest in cessation: the global investment case for tobacco cessation [EB/OL]. (2021-11-16)[2024-5-11]. https://www.who.int/publications/i/item/9789240039308. |
[16] |
BIALOUS S, DA COSTA E SILVA V L. Where next for the WHO framework convention on tobacco control?[J]. Tob Control, 2022, 31(2):183-186. doi: 10.1136/tobaccocontrol-2021-056545 |
[17] |
MATTHES B K, ROBERTSON L, GILMORE A B. Needs of LMIC-based tobacco control advocates to counter tobacco industry policy interference: insights from semi-structured interviews[J]. BMJ Open, 2020, 10(11):e044710. doi: 10.1136/bmjopen-2020-044710 |
[18] |
KAUR J, RINKOO A V, GOUDA H N, et al. Implementation of MPOWER package in the south-east Asia Region: evidence from the WHO report on the global tobacco epidemic(2009-2021)[J]. Asian Pac J Cancer Prev, 2021, 22(S2):71-80. doi: 10.31557/APJCP.2021.22.S2.71 |
[19] |
World Health Organization. Quitting tobacco[EB/OL]. [2024-05-11]. https://www.who.int/activities/quitting-tobacco. |
[20] |
World Health Organization. WHO Global report on trends in prevalence of tobacco use 2000–2030 [EB/OL]. (2024-01-16)[2024-06-02]. https://www.who.int/publications/i/item/9789240088283. |
[21] |
World Health Organization. MPOWER[EB/OL].(2023-07-31)[2024-05-11]. https://www.who.int/initiatives/mpower. |
[22] |
Joint WHO-FIP statement on the role of pharmacists in tobacco cessation[EB/OL]. (2024-05-31)[2024-06-02]. https://www.fip.org/file/5871. |
[23] |
CRESWELL P D, MCCARTHY D E, TRAPSKIN P, et al. Can inpatient pharmacists move the needle on smoking cessation? Evaluating reach and representativeness of a pharmacist-led opt-out smoking cessation intervention protocol for hospital settings[J]. Am J Health Syst Pharm, 2022, 79(12):969-978. doi: 10.1093/ajhp/zxab488 |
[24] |
PHILLIPS L C E, NGUYEN H, GENGE T L, et al. Effectiveness and cost-effectiveness of an intensive and abbreviated individualized smoking cessation program delivered by pharmacists: a pragmatic, mixed-method, randomized trial[J]. Rev Des Pharm Du Can, 2022, 155(6):334-344. doi: 10.1177/17151635221128263 |
[25] |
TRAPSKIN P J, SHEEHY A, CRESWELL P D, et al. Development of a pharmacist-led opt-out cessation treatment protocol for combustible tobacco smoking within inpatient settings[J]. Hosp Pharm, 2022, 57(1):167-175. doi: 10.1177/0018578721999809 |
[26] |
THOMAS T, SYKES B, SHAH S, et al. Pharmacist prescriber smoking cessation intervention during the COVID-19 pandemic[J]. Tob Induc Dis, 2023, 21:142. |
[27] |
JANN S, LINDSAY K. Promising Practices for Pharmacist Engagement in Tobacco Cessation Interventions: American Pharmacists Association[EB/OL]. (2020-09-01)[2024-06-02]. https://aphanet.pharmacist.com/sites/default/files/audience/APhAPromisingPracticesTobCess_web_2020.pdf. |
[28] |
GÓMEZ MARTÍNEZ J C, GAZTELURRUTIA LAVESA L, MENDOZA BARBERO A, et al. Smoking cessation intervention in the community pharmacy: cost-effectiveness of a non-randomized cluster-controlled trial at 12-months' follow-up[J]. Res Social Adm Pharm, 2024, 20(1):19-27. doi: 10.1016/j.sapharm.2023.09.003 |
[29] |
EL HAJJ M S, AWAISU A, NIK MOHAMED M H, et al. Assessment of an intensive education program for pharmacists on treatment of tobacco use disorder using an objective structured clinical examination: a randomized controlled trial[J]. BMC Med Educ, 2022, 22(1):289. doi: 10.1186/s12909-022-03331-9 |
[30] |
ERKU D A, HAILEMESKEL B, NETERE A K, et al. Pharmacist-led smoking cessation services in Ethiopia: knowledge and skills gap analysis[J]. Tob Induc Dis, 2019, 17:01. |
[31] |
GREENHALGH T, MACFARLANE F, STEED L, et al. What works for whom in pharmacist-led smoking cessation support: realist review[J]. BMC Med, 2016, 14(1):209. doi: 10.1186/s12916-016-0749-5 |
[32] |
NEWLON J, HILTS K E, CHAMPION V, et al. Bridging the gap in tobacco cessation services: utilizing community pharmacists to facilitate transitions of care in the USA[J]. J Gen Intern Med, 2022, 37(11):2840-2844. doi: 10.1007/s11606-022-07546-w |
[33] |
BOUCHET-BENEZECH B, CHAMPANET B, ROUZAUD P. Smoking cessation at the pharmacy: feasibility and benefits based on a French observational study with six-month follow-up[J]. Subst Abuse Rehabil, 2018, 9:31-42. doi: 10.2147/SAR.S152186 |
[34] |
SABA M, DIEP J, SAINI B, et al. Meta-analysis of the effectiveness of smoking cessation interventions in community pharmacy[J]. J Clin Pharm Ther, 2014, 39(3):240-247. doi: 10.1111/jcpt.12131 |
[35] |
PELETIDI A, NABHANI-GEBARA S, KAYYALI R. Smoking cessation support services at community pharmacies in the UK: a systematic review[J]. Hellenike Kardiologike Epitheorese, 2016, 57(1):7-15. |
[36] |
LERTSINUDOM S, KAEWKETTHONG P, CHANKAEW T, et al. Smoking cessation services by community pharmacists: real-world practice in Thailand[J]. Int J Environ Res Public Health, 2021, 18(22):11890. doi: 10.3390/ijerph182211890 |
[37] |
CSIKAR J I, DOUGLAS G V, PAVITT S, et al. The cost-effectiveness of smoking cessation services provided by general dental practice, general medical practice, pharmacy and NHS Stop Smoking Services in the North of England[J]. Community Dent Oral Epidemiol, 2016, 44(2):119-127. doi: 10.1111/cdoe.12195 |
[38] |
BEAUPRE L A, HAMMAL F, STIEGELMAR R, et al. A community-based pharmacist-led smoking cessation program, before elective total joint replacement surgery, markedly enhances smoking cessation rates[J]. Tob Induc Dis, 2020, 18:78. |
[39] |
JUMBE S, MADURASINGHE V W, JAMES W Y, et al. STOP-a training intervention to optimise treatment for smoking cessation in community pharmacies: cluster randomised controlled trial[J]. BMC Med, 2022, 20(1):212. doi: 10.1186/s12916-022-02412-2 |
[40] |
SAKKA S, AL-SHATANAWI T N, BATAINEH D Z, et al. Knowledge, attitude, practice and perceived barriers towards smoking cessation services among community pharmacists[J]. Pharm Pract, 2022, 20(1):2637. |